Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04386057
Title LY3214996 +/- HCQ in Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Brian Wolpin, MD, MPH
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field